Get the Stockscreener App
2.55
2.41%
0.06
Orchestra Biomed Holdings Inc stock is traded at $2.55, with a volume of 188.32K.
It is up +2.41% in the last 24 hours and down -20.31% over the past month.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
See More
Previous Close:
$2.49
Open:
$2.5
24h Volume:
188.32K
Relative Volume:
0.61
Market Cap:
$137.59M
Revenue:
$2.76M
Net Income/Loss:
$-49.12M
P/E Ratio:
-1.70
EPS:
-1.5
Net Cash Flow:
$-46.21M
1W Performance:
-0.58%
1M Performance:
-20.31%
6M Performance:
-45.97%
1Y Performance:
-58.74%
1-Day Range:
$2.50
$2.59
1-Week Range:
$2.38
$2.66
52-Week Range:
$2.37
$7.04
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Name
Orchestra Biomed Holdings Inc
Sector
Industry
Phone
646-343-9298
Address
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
2.55 | 141.90M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-20-25 | Initiated | BTIG Research | Buy |
| Jan-02-25 | Initiated | Barclays | Overweight |
| Aug-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-25-24 | Initiated | B. Riley Securities | Buy |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Feb-24-23 | Initiated | Piper Sandler | Overweight |
| Feb-07-23 | Initiated | Chardan Capital Markets | Buy |
View All
Orchestra Biomed Holdings Inc Stock (OBIO) Latest News
Volatility clustering patterns for Orchestra BioMed Holdings Inc.Dollar Strength & Fast Entry High Yield Stock Tips - Newser
Orchestra BioMed Study Shows AVIM Therapy Could Transform Care for Hypertensive Heart Disease - MSN
Is Orchestra BioMed Holdings Inc. building a consolidation base2025 Big Picture & Real-Time Stock Entry Alerts - Newser
Orchestra BioMed Secures $111M to Advance Late-Stage Cardiac Therapies, Hits Multiple FDA Milestones - MSN
Orchestra BioMed Shares Fall After BTIG Downgrade - MarketScreener
Orchestra BioMed Holdings Inc. Building a Base Near SupportWeekly Trade Review & Real-Time Sentiment Analysis - classian.co.kr
How to read the order book for Orchestra BioMed Holdings Inc.July 2025 Fed Impact & Daily Market Momentum Tracking - Newser
This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Orchestra BioMed stock rating downgraded to Neutral from Buy by BTIG - Investing.com
BTIG Downgrades Orchestra BioMed to Neutral From Buy - MarketScreener
Will a bounce in Orchestra BioMed Holdings Inc. offer an exitMarket Risk Analysis & Free Fast Gain Swing Trade Alerts - Newser
Is Orchestra BioMed Holdings Inc. stock bottoming outMarket Performance Recap & Breakout Confirmation Alerts - Newser
Will Orchestra BioMed Holdings Inc. rebound enough to break even2025 Price Momentum & Consistent Income Trade Ideas - Newser
Understanding Orchestra BioMed Holdings Inc.’s price movement2025 Fundamental Recap & AI Powered Trade Plan Recommendations - Newser
Long term hold vs stop loss in Orchestra BioMed Holdings Inc.Weekly Earnings Recap & Low Drawdown Investment Strategies - Newser
Short interest data insights for Orchestra BioMed Holdings Inc.2025 Institutional Moves & Accurate Entry/Exit Alerts - Newser
Applying sector rotation models to Orchestra BioMed Holdings Inc.2025 Performance Recap & Advanced Swing Trade Entry Plans - Newser
How to monitor Orchestra BioMed Holdings Inc. with trend dashboardsShare Buyback & Verified Trade Idea Suggestions - Newser
What the charts say about Orchestra BioMed Holdings Inc. todayWeekly Stock Analysis & Community Verified Trade Signals - Newser
Smart tools for monitoring Orchestra BioMed Holdings Inc.’s price action2025 Retail Activity & Stepwise Trade Signal Implementation - Newser
Can Orchestra BioMed Holdings Inc. hit a new high this monthQuarterly Earnings Summary & Fast Gain Stock Trading Tips - Newser
Is a relief rally coming for Orchestra BioMed Holdings Inc. holdersWeekly Trade Report & Capital Efficient Trading Techniques - Newser
Does Orchestra BioMed Holdings Inc. fit your quant trading modelEarnings Risk Report & Verified Swing Trading Watchlists - Newser
Historical volatility pattern of Orchestra BioMed Holdings Inc. visualizedJuly 2025 Fed Impact & AI Optimized Trading Strategy Guides - Newser
Heatmap analysis for Orchestra BioMed Holdings Inc. and competitorsMarket Growth Report & Reliable Entry Point Trade Alerts - Newser
Orchestra BioMed Reports Q2 2025 Financial Results - TipRanks
Real time pattern detection on Orchestra BioMed Holdings Inc. stockEarnings Summary Report & Weekly Market Pulse Updates - Newser
Is Orchestra BioMed Holdings Inc. a candidate for recovery playWeekly Trade Summary & Weekly Hot Stock Watchlists - Newser
Will Orchestra BioMed Holdings Inc. continue its uptrend2025 Momentum Check & Stock Portfolio Risk Management - Newser
What data driven models say about Orchestra BioMed Holdings Inc.’s future2025 Top Decliners & Reliable Entry Point Alerts - Newser
How hedge fund analytics apply to Orchestra BioMed Holdings Inc. stock2025 Earnings Surprises & Technical Buy Zone Confirmations - Newser
Best data tools to analyze Orchestra BioMed Holdings Inc. stockPrice Action & Daily Oversold Stock Bounce Ideas - Newser
Advanced analytics toolkit walkthrough for Orchestra BioMed Holdings Inc2025 Breakouts & Breakdowns & Free Expert Approved Momentum Trade Ideas - Newser
Reversal indicators forming on Orchestra BioMed Holdings Inc. stockWeekly Stock Recap & Accurate Buy Signal Alerts - Newser
Real time scanner hits for Orchestra BioMed Holdings Inc. explainedTrade Risk Summary & Community Shared Stock Ideas - Newser
Signal strength of Orchestra BioMed Holdings Inc. stock in tech scannersShare Buyback & Fast Gain Stock Tips - Newser
Intrinsic Value of Orchestra BioMed Holdings Inc. Stock: Is It Undervalued or OvervaluedJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - Newser
Can momentum traders help lift Orchestra BioMed Holdings Inc.2025 Top Gainers & Verified Entry Point Signals - Newser
Advanced analytics toolkit walkthrough for Orchestra BioMed Holdings Inc.Earnings Trend Report & Expert Approved Momentum Ideas - Newser
Orchestra Biomed Holdings Inc Stock (OBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Orchestra Biomed Holdings Inc Stock (OBIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hochman David P | See Remarks |
Aug 04 '25 |
Buy |
2.75 |
20,000 |
55,000 |
349,331 |
| Fain Eric S | Director |
Jun 26 '25 |
Sale |
3.05 |
2,683 |
8,183 |
50,949 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):